Ceacam1 - CEA cell adhesion molecule 1 Gene

Also Known as Bgp; BGPR; CD66a; Ccam1

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 81613

Summary

Enables several functions, including bile acid transmembrane transporter activity; Calmodulin binding activity; and protein homodimerization activity. Involved in several processes, including homophilic cell adhesion via plasma membrane adhesion molecules; Insulin catabolic process; and regulation of signal transduction. Acts upstream of or within positive regulation of MAP kinase activity. Located in several cellular components, including adherens junction; basal plasma membrane; and lateral plasma membrane. Orthologous to several human genes including CEACAM1 (CEA cell adhesion molecule 1). [provided by Alliance of Genome Resources, Apr 2022]

Ceacam1 Products (4)

mRNA Protein Name
NM_001033860.1 NP_001029032.1 carcinoembryonic antigen-related cell adhesion molecule 1 isoform 1 precursor
NM_001033861.1 NP_001029033.1 carcinoembryonic antigen-related cell adhesion molecule 1 isoform 2 precursor
NM_001033862.1 NP_001029034.1 carcinoembryonic antigen-related cell adhesion molecule 1 isoform 3 precursor
NM_031755.2 NP_113943.1 carcinoembryonic antigen-related cell adhesion molecule 1 isoform 4 precursor
Protein Preferred Names Protein Names

carcinoembryonic antigen-related cell adhesion molecule 1

  • ATP-dependent taurocolate-carrier protein

  • C-CAM 105

  • CEA-related cell adhesion molecule 1 (bone gamma-carboxyglutamic acid (Gla) protein) (osteocalcin)

  • GP110

  • bone gamma-carboxyglutamic acid (Gla) protein

  • carcinoembryonic antigen related cell adhesion

Recombinant Ceacam1 Proteins

Cat. No. Product Name Accession Purity
HY-P75358 CEACAM1 Protein, Rat (HEK293, His) P16573-1 (Q35-S422) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Phase
HY-P990569 CM-24 96.02% Phase 2
HY-P991396 LY-3321367 Inhibitor 99.0% Phase 1

Pre-clinical Phase

Bioactive Molecules (6)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-163028 ML-T7 99.93% Unkown
HY-155175 TIM-3-IN-2 99.44% Unkown
HY-159884 MG-T-19 98.34% Unkown
HY-RS02435 CEACAM1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17387 Ceacam1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23842 Ceacam1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (6)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990821 Anti-Mouse TIM-3 Antibody (RMT3-23) Inhibitor 99.64% Unkown
HY-P990004 Anti-Mouse TIM-3 Antibody (B8.2C12) Inhibitor 99.48% Unkown
HY-P991198 M6903 Ligand 98.81% Unkown
HY-P990364 Anti-CEACAM1/CD66a Antibody Inhibitor / Unkown
HY-P992344 DNP002 Inhibitor / Unkown
HY-P990854 Anti-CEACAM1/3/5/6/8 Antibody (6G5j) Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Ceacam1 NCBI NCBI:634